A de novo acute myeloid leukemia (AML-M4) case with a complex karyotype and yet unreported breakpoints
- PMID: 23641812
- PMCID: PMC3658984
- DOI: 10.1186/1755-8166-6-18
A de novo acute myeloid leukemia (AML-M4) case with a complex karyotype and yet unreported breakpoints
Abstract
Background: Acute myelogeneous leukemia (AML) is a malignancy of the hematopoietic stem cells, for which cytogenetic analysis is still one of the most important diagnostic and prognostic tools. Still, we are far away from having seen and described all possible genetic changes associated with this kind of acquired disease.
Results: Bone marrow cells of a female patient with clinical diagnoses of AML and immunophenotypically confirmed AML-M4 were studied by GTG-banding. The later was not able to resolve all karyotypic changes and the complex karyotype was characterized in more detail by fluorescence in situ hybridization (FISH) and array-proven multicolor banding (aMCB). To the best of our knowledge, the present case is the only one ever seen with a del(5)(q14q34), a der(17)t(4;17)(p13;p13), a del(2)(p23), a der(4)t(4;7)(p13;q11.23), a der(22)t(11;22)(q23;q11.2) and two complex rearranged chromosomes 11 involving chromosomes 7 and 22 as well as 2.
Conclusions: The yet unreported breakpoints observed in this case seem to be correlated with an adverse prognosis. Overall, molecular cytogenetic studies are suited best for identification and characterization of chromosomal rearrangements in acute leukemia and single case reports as well as large scale studies are necessary to provide further insides in karyotypic changes taking place in human malignancies.
Figures



Similar articles
-
An adult B-cell precursor acute lymphoblastic leukemia with multiple secondary cytogenetic aberrations.Mol Cytogenet. 2014 Sep 10;7(1):60. doi: 10.1186/s13039-014-0060-0. eCollection 2014. Mol Cytogenet. 2014. PMID: 25254075 Free PMC article.
-
[Clinical and experimental studies of childhood acute myeloid leukemia with 11q23/MLL rearrangements].Zhonghua Yi Xue Yi Chuan Xue Za Zhi. 2012 Dec;29(6):677-82. doi: 10.3760/cma.j.issn.1003-9406.2012.06.011. Zhonghua Yi Xue Yi Chuan Xue Za Zhi. 2012. PMID: 23225048 Chinese.
-
Highly complex karyotypic changes in acute myelogenous leukemia: a case report.Int J Oncol. 2003 Jul;23(1):139-43. Int J Oncol. 2003. PMID: 12792786
-
Acute myeloid leukemia with inv(16) with CBFB-MYH11, 3'CBFB deletion, variant t(9;22) with BCR-ABL1, and del(7)(q22q32) in a pediatric patient: case report and literature review.Cancer Genet Cytogenet. 2010 Jul 1;200(1):54-9. doi: 10.1016/j.cancergencyto.2010.03.001. Cancer Genet Cytogenet. 2010. PMID: 20513535 Review.
-
Acquired chromosomal rearrangements targeting selected transcription factors: contribution of molecular cytogenetic and expression analyses to the identification of clinically and biologically relevant subgroups in hematological malignancies.Verh K Acad Geneeskd Belg. 2007;69(1):47-64. Verh K Acad Geneeskd Belg. 2007. PMID: 17427874 Review.
Cited by
-
New translocation in acute myeloid leukemia M4 eos.Leuk Res Rep. 2020 Jun 8;14:100209. doi: 10.1016/j.lrr.2020.100209. eCollection 2020. Leuk Res Rep. 2020. PMID: 32566479 Free PMC article.
-
Banding cytogenetic analysis in pediatric patients with acute lymphoblastic leukemia (ALL) in a Brazilian population.Mol Cytogenet. 2013 Sep 11;6(1):37. doi: 10.1186/1755-8166-6-37. Mol Cytogenet. 2013. PMID: 24025689 Free PMC article.
References
-
- Byrd JC, Mrozek K, Dodge RK, Carroll AJ, Edwards CG, Arthur DC, Pettenati MJ, Patil SR, Rao KW, Watson MS, Koduru PR, Moore JO, Stone RM, Mayer RJ, Feldman EJ, Davey FR, Schiffer CA, Larson RA, Bloomfield CD. Cancer and Leukemia Group B (CALGB8461) Pretreatment cytogenetic abnormalities are predictive of induction success, cumulative incidence of relapse, and overall survival in adult patients with de novo acute myeloid leukemia: results from Cancer and Leukemia Group B (CALGB 8461) Blood. 2002;100:4325–4336. doi: 10.1182/blood-2002-03-0772. - DOI - PubMed
-
- Grimwade D, Walker H, Oliver F, Wheatley K, Harrison C, Harrison G, Rees J, Hann I, Stevens R, Burnett A, Goldstone A. The importance of diagnostic cytogenetics on outcome in AML: analysis of 1,612 patients entered into the MRC AML 10 trial. The medical research council adult and children’s leukaemia working parties. Blood. 1998;92:2322–2333. - PubMed
-
- Mrozek K, Heinonen K, Bloomfield CD. Prognostic value of cytogenetic findings in adults with acute myeloid leukemia. Int J Hematol. 2000;72:261–271. - PubMed
Publication types
LinkOut - more resources
Full Text Sources
Other Literature Sources